Dexcom

DXCM

NASDAQ·Health Care

Market Cap
-
P/E Ratio
-
Dividend Yield
-

Company Overview

Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Industry
Health Care Equipment

Financial Summary

Revenue (TTM)
$116.20M
Net Income (TTM)
$341.20M
Total Assets
$6.26B
Total Debt
$4.60M
Total Equity
$2.04B
Market Cap
-

Valuation Metrics

P/E Ratio
-
P/B Ratio
-
Profit Margin
293.63%
ROE
16.71%
ROA
5.45%
Dividend Yield
-